Sort
82,697 grants matching “vaccine development”
NORTH CAROLINA STD COOPERATIVE RESEARCH CENTER
$1,115,372University Of North Carolina Chapel Hill · U19 · FY2002 · AI
Genomic Studies of the Impact of External Factors on Parasite Development and Disease Outcome
$1,115,342Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2023 · AI
Collaborative Modeling for Assessment and Optimization in Public Health
$1,114,972Marc Lipsitch · Harvard School Of Public Health · U54 · FY2017 · GM
Collaborative Modeling for Assessment and Optimization in Public Health
$1,114,972Marc Lipsitch · Harvard School Of Public Health · U54 · FY2016 · GM
Vaccines to counter emerging antibiotic resistance
$1,114,852Wendy L Picking · University Of Kansas Lawrence · R01 · FY2019 · AI
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$1,114,686Mark Fredric Cotton · Stellenbosch University · UM1 · FY2016 · AI
MHC-bound, SIV-derived, CTL and HTL Epitopes
$1,114,629David I Watkins · University Of Miami School Of Medicine · R24 · FY2012 · OD
UAB AIEDRP: Immune Control and Escape in Acute Infection
$1,114,589University Of Alabama At Birmingham · U01 · FY2003 · AI
Protective and pathogenic B cell epitopes in Francisella tularensis
$1,114,361Jacqueline Sharon · Boston University (Charles River Campus) · N01 · FY2009 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,114,342Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Oral Antiviral Prodrugs for Biodefense Initiative
$1,114,210John M Hilfinger · Tsrl, Inc. · U01 · FY2009 · AI
Clinical Trials of Immunotherapies for Childhood Cancer
$1,113,902Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Administrative Core and Data Management Center
$1,113,900Henry M Blumberg · Emory University · U19 · FY2019 · AI
Production of New Adenovector Constructs with Fiber-Shaft Modifications
$1,113,792Kimberly Wallace · Niaid Extramural Activities · Z01 · FY2007 · AI
CHLAMYDIA TRACHOMATIS VACCINE SAFETY AND EFFICACY EVALUATION IN NONHUMAN PRIMATES
$1,113,776Dorothy Patton · University Of Washington · N01 · FY2014 · AI
Antigenicity and Immunogenicity of Stabilized prefusion F protein
$1,113,346Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Genome-wide CRISPRa screen to determine the antiviral repertoire of the cell
$1,113,198Rebecca Broeckel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Development of a Universal Influenza Seasonal Vaccine
$1,113,078David B. Weiner · University Of Pennsylvania · R01 · FY2012 · AI
Discovery of new anti-bacteremia vaccines for anthrax
$1,112,995Macrogenics, Inc. · U01 · FY2003 · AI
Viruses and Hematopoiesis
$1,112,843Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Biochemical and structural mechanisms at the filoviral-host interface
$1,112,463Gaya K. Amarasinghe · Washington University · P01 · FY2023 · AI
Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance
$1,112,000Anthony Bernard Schryvers · University Of Calgary · R01 · FY2019 · AI
Vaccines for Extensively Drug Resistant Tuberculosis
$1,111,872William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI
Vaccines for Extensively Drug Resistant Tuberculosis
$1,111,872William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2014 · AI
Monoclonal Antibodies in Biodefense: Ebola Viruses
$1,111,806Larry Zeitlin · Mapp Biopharmaceutical, Inc. · U01 · FY2008 · AI